Ono enters into license agreement for LCB97, an Antibody-Drug Conjugate, and research collaboration and license...

MediLink Therapeutics and Amgen announce global clinical collaboration to evaluate combination therapy for Extensive-Stage Small...

FDA gives Adcendo green light to trial ADC in Phase I/II sarcoma study

CSPC Pharmaceutical announces CPO301 receives Fast Track Designation (FTD) from US FDA

AstraZeneca’s dual-antibody ADC approved for two clinical trials in China